Approval · Notice of Compliance 12304 · 2011
METHOTREXATE: Notice of Compliance 12304
Issued May 2, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12304
- Date
- May 2, 2011
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antimetabolite
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METHOTREXATE | 02170671 | Cancelled Post Market |
Medicinal ingredients
- METHOTREXATE 25 MG per ML